.png)
Gene Editing Market By Product, Technology and Application - Global Industry Analysis And Forecast To 2027
Published On : December 2018 Pages : 160 Category: Healthcare IT Report Code : HC122176
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Gene Editing Market By Product (Instruments, Cell Lines & Animal Models and Software And Reagents and Consumables); Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nucleases (ZFN), Transcriptor-Activator-Like Effector Nuclease (TALEN) and Other) and Application (Biotechnology, Drug Discovery & Development, Agriculture and Scientific Research) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Gene editing is also referred to as genome editing. Genome is defined as the full DNA strand. Gene Editing is a procedure carried out to cut and replace a part of living organism. Gene Editing has various applications in sectors like agriculture (for increasing the output, developing crops that are tolerant to diseases and environmental changes); industrial biotechnology (for developing different materials, chemicals, pharmaceuticals, etc.); reproduction (for removing any traces of hereditary disease); etc. Gene editing is seen as a hopeful procedure for eradicating disorders and developing a good product in the field of genetic research. Therefore these are the factors due to which, the Gene Editing Market is anticipated to expand and has tremendous scope during the forecast period. The global Gene Editing Market is anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Gene Editing Market is based on segment, by Product the market is segmented into Instruments, Cell Lines & Animal Models and Software And Reagents and Consumables; by Technology the market is segmented into Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nucleases (ZFN), Transcriptor-Activator-Like Effector Nuclease (TALEN) and Other; and by Application the market is segmented into Biotechnology, Drug Discovery & Development, Agriculture and Scientific Research.
- Gene Editing Market, By Product
- Instruments
- Cell Lines & Animal Models and Software
- Reagents and Consumables
- Gene Editing Market, By Technology
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Zinc Finger Nucleases (ZFN)
- Transcriptor-Activator-Like Effector Nuclease (TALEN)
- Other
- Gene Editing Market, Application
- Biotechnology
- Drug Discovery & Development
- Agriculture
- Scientific Research
Regional Insights
On a global front, the Gene Editing Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). Gene Editing Market is led by North American region due to use of recent gene editing beforehand, number of key companies being present and increasing knowledge regarding the technology.
Gene Editing Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Sangamo Biosciences, Parker Institute, Editas Medicine, Intellia Therapeutics, Thermo Fisher Scientific, Cellectis, Crispr Therapeutics and Merck. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Sangamo Biosciences
- Parker Institute
- Editas Medicine
- Intellia Therapeutics
- Thermo Fisher Scientific
- Cellectis
- Crispr Therapeutics
- Merck Alma Lasers Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Gene Editing Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Instruments
o Cell Lines & Animal Models and Software
o Reagents and Consumables
o Gene Editing Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
o Zinc Finger Nucleases (ZFN)
o Transcriptor-Activator-Like Effector Nuclease (TALEN)
o Other
o Gene Editing Market, By Application , Estimates and Forecast, 2017-2027 ($Million)
o Biotechnology
o Drug Discovery & Development
o Agriculture
o Scientific Research
Gene Editing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Gene Editing Market, By Country
o U.S. Gene Editing Market
o Canada Gene Editing Market
o Mexico Gene Editing Market
o Europe
§ Europe Gene Editing Market, By Country
o Germany Gene Editing Market
o UK Gene Editing Market
o France Gene Editing Market
o Russia Gene Editing Market
o Italy Gene Editing Market
o Rest of Europe Gene Editing Market
o Asia-Pacific
§ Asia-Pacific Gene Editing Market, By Country
o China Gene Editing Market
o Japan Gene Editing Market
o South Korea Gene Editing Market
o India Gene Editing Market
o Southeast Asia Gene Editing Market
o Rest of Asia-Pacific Gene Editing Market
o South America
§ South America Gene Editing Market, By Country
o Brazil Gene Editing Market
o Argentina Gene Editing Market
o Columbia Gene Editing Market
o Rest of South America Gene Editing Market
o Middle East and Africa
§ Middle East and Africa Gene Editing Market, By Country
o Saudi Arabia Gene Editing Market
o UAE Gene Editing Market
o Egypt Gene Editing Market
o Nigeria Gene Editing Market
o South Africa Gene Editing Market
o Rest of MEA Gene Editing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2027)
4.1.2. Canada Market States and Outlook (2017-2027)
4.1.3. Mexico Market States and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2027)
4.2.2. France Market States and Outlook (2017-2027)
4.2.3. UK Market States and Outlook (2017-2027)
4.2.4. Russia Market States and Outlook (2017-2027)
4.2.5. Italy Market States and Outlook (2017-2027)
4.2.6. Rest of Europe Market States and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2027)
4.3.2. Japan Market States and Outlook (2017-2027)
4.3.3. Korea Market States and Outlook (2017-2027)
4.3.4. India Market States and Outlook (2017-2027)
4.3.5. Southeast Asia Market States and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2027)
4.4.2. Argentina Market States and Outlook (2017-2027)
4.4.3. Columbia Market States and Outlook (2017-2027)
4.4.4. Rest of South America Market States and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2027)
4.5.2. United Arab Emirates Market States and Outlook (2017-2027)
4.5.3. Egypt Market States and Outlook (2017-2027)
4.5.4. Nigeria Market States and Outlook (2017-2027)
4.5.5. South Africa Market States and Outlook (2017-2027)
4.5.6. Turkey Market States and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)
5. Gene Editing Market, By Product
5.1. Introduction
5.2. Global Gene Editing Revenue and Market Share by Product (2017-2027)
5.2.1. Global Gene Editing Revenue and Revenue Share by Product (2017-2027)
5.3. Instruments
5.3.1. Global Instruments Revenue and Growth Rate (2017-2027)
5.4. Cell Lines & Animal Models and Software
5.4.1. Global Cell Lines & Animal Models and Software Revenue and Growth Rate (2017-2027)
5.5. Reagents and Consumables
5.5.1. Global Reagents and Consumables Revenue and Growth Rate (2017-2027)
6. Gene Editing Market, By Technology
6.1. Introduction
6.2. Global Gene Editing Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Gene Editing Revenue and Revenue Share by Technology (2017-2027)
6.3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
6.3.1. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Revenue and Growth Rate (2017-2027)
6.4. Zinc Finger Nucleases (ZFN)
6.4.1. Global Zinc Finger Nucleases (ZFN) Revenue and Growth Rate (2017-2027)
6.5. Transcriptor-Activator-Like Effector Nuclease (TALEN)
6.5.1. Global Transcriptor-Activator-Like Effector Nuclease (TALEN) Revenue and Growth Rate (2017-2027)
6.6. Other
6.6.1. Global Other Revenue and Growth Rate (2017-2027)
7. Gene Editing Market, By Application
7.1. Introduction
7.2. Global Gene Editing Revenue and Market Share by Application (2017-2027)
7.2.1. Global Gene Editing Revenue and Revenue Share by Application (2017-2027)
7.3. Biotechnology
7.3.1. Global Biotechnology Revenue and Growth Rate (2017-2027)
7.4. Drug Discovery & Development
7.4.1. Global Drug Discovery & Development Revenue and Growth Rate (2017-2027)
7.5. Agriculture
7.5.1. Global Agriculture Revenue and Growth Rate (2017-2027)
7.6. Scientific Research
7.6.1. Global Scientific Research Revenue and Growth Rate (2017-2027)
8. Gene Editing Market, By Region
8.1. Introduction
8.2. Global Gene Editing Revenue and Market Share by Regions
8.2.1. Global Gene Editing Revenue by Regions (2017-2027)
8.3. North America Gene Editing by Countries
8.3.1. North America Gene Editing Revenue and Growth Rate (2017-2027)
8.3.2. North America Gene Editing Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Gene Editing by Countries
8.4.1. Europe Gene Editing Revenue and Growth Rate (2017-2027)
8.4.2. Europe Gene Editing Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Gene Editing by Countries
8.5.1. Asia-Pacific Gene Editing Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Gene Editing by Countries
8.6.1. South America Gene Editing Revenue and Growth Rate (2017-2027)
8.6.2. South America Gene Editing Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Gene Editing by Countries
8.7.1. Middle East and Africa Gene Editing Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Sangamo Biosciences
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Parker Institute
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Editas Medicine
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Intellia Therapeutics
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Thermo Fisher Scientific
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Cellectis
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Crispr Therapeutics
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Merck Alma Lasers Ltd.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
10. Global Gene Editing Market Competition, by Manufacturer
10.1. Global Gene Editing Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Gene Editing Price By Region (2017-2017)
10.3. Top 5 Gene Editing Manufacturer Market Share
10.4. Market Competition Trend
11. Gene Editing Market Forecast (2017-2027)
11.1. Global Gene Editing Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Gene Editing Market Forecast by Regions (2017-2027)
11.2.1. North America Gene Editing Market Forecast (2017-2027)
11.2.1.1. United States Gene Editing Market Forecast (2017-2027)
11.2.1.2. Canada Gene Editing Market Forecast (2017-2027)
11.2.1.3. Mexico Gene Editing Market Forecast (2017-2027)
11.2.2. Europe Gene Editing Market Forecast (2017-2027)
11.2.2.1. Germany Gene Editing Market Forecast (2017-2027)
11.2.2.2. France Gene Editing Market Forecast (2017-2027)
11.2.2.3. UK Gene Editing Market Forecast (2017-2027)
11.2.2.4. Russia Gene Editing Market Forecast (2017-2027)
11.2.2.5. Italy Gene Editing Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Gene Editing Market Forecast (2017-2027)
11.2.3. Asia-Pacific Gene Editing Market Forecast (2017-2027)
11.2.3.1. China Gene Editing Market Forecast (2017-2027)
11.2.3.2. Japan Gene Editing Market Forecast (2017-2027)
11.2.3.3. Korea Gene Editing Market Forecast (2017-2027)
11.2.3.4. India Gene Editing Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Gene Editing Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Gene Editing Market Forecast (2017-2027)
11.2.4. South America Gene Editing Market Forecast (2017-2027)
11.2.4.1. Brazil Gene Editing Market Forecast (2017-2027)
11.2.4.2. Argentina Gene Editing Market Forecast (2017-2027)
11.2.4.3. Columbia Gene Editing Market Forecast (2017-2027)
11.2.4.4. Rest of South America Gene Editing Market Forecast (2017-2027)
11.2.5. Middle East and Africa Gene Editing Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Gene Editing Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Gene Editing Market Forecast (2017-2027)
11.2.5.3. Egypt Gene Editing Market Forecast (2017-2027)
11.2.5.4. Nigeria Gene Editing Market Forecast (2017-2027)
11.2.5.5. South Africa Gene Editing Market Forecast (2017-2027)
11.2.5.6. Turkey Gene Editing Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Gene Editing Market Forecast (2017-2027)
11.3. Gene Editing Market Forecast by Product (2017-2027)
11.3.1. Gene Editing Forecast by Product (2017-2027)
11.3.2. Gene Editing Market Share Forecast by Product (2017-2027)
11.4. Gene Editing Market Forecast by Technology (2017-2027)
11.4.1. Gene Editing Forecast by Technology (2017-2027)
11.4.2. Gene Editing Market Share Forecast by Technology (2017-2027)
11.5. Gene Editing Market Forecast by Application (2017-2027)
11.5.1. Gene Editing Forecast by Application (2017-2027)
11.5.2. Gene Editing Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Gene Editing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Gene Editing Revenue and Revenue Share by Product (2017-2018)
Figure Global Instruments Revenue and Growth Rate (2017-2018)
Figure Global Cell Lines & Animal Models and Software Revenue and Growth Rate (2017-2018)
Figure Global Reagents and Consumables Revenue and Growth Rate (2017-2018)
Table Global Gene Editing Revenue and Revenue Share by Technology (2017-2018)
Figure Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Revenue and Growth Rate (2017-2018)
Figure Global Zinc Finger Nucleases (ZFN) Revenue and Growth Rate (2017-2018)
Figure Global Transcriptor-Activator-Like Effector Nuclease (TALEN) Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Gene Editing Revenue and Revenue Share by Application (2017-2018)
Figure Global Biotechnology Revenue and Growth Rate (2017-2018)
Figure Global Drug Discovery & Development Revenue and Growth Rate (2017-2018)
Figure Global Agriculture Revenue and Growth Rate (2017-2018)
Figure Global Scientific Research Revenue and Growth Rate (2017-2018)
Table Global Gene Editing Revenue by Regions (2017-2018)
Figure North America Gene Editing Growth Rate (2017-2018)
Figure North America Gene Editing Revenue and Growth Rate (2017-2018)
Figure North America Gene Editing by Countries (2017-2018)
Figure North America Gene Editing Revenue (Million USD) by Countries (2017-2018)
Figure United States Gene Editing Growth Rate (2017-2018)
Figure United States Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Gene Editing Growth Rate (2017-2018)
Figure Canada Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Gene Editing Growth Rate (2017-2018)
Figure Mexico Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Gene Editing Growth Rate (2017-2018)
Figure Europe Gene Editing Revenue and Growth Rate (2017-2018)
Figure Europe Gene Editing by Countries (2017-2018)
Figure Europe Gene Editing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Gene Editing Growth Rate (2017-2018)
Figure Germany Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Gene Editing Growth Rate (2017-2018)
Figure France Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Gene Editing Growth Rate (2017-2018)
Figure UK Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Gene Editing Growth Rate (2017-2018)
Figure Russia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Gene Editing Growth Rate (2017-2018)
Figure Italy Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Gene Editing Growth Rate (2017-2018)
Figure Rest of Europe Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Gene Editing Growth Rate (2017-2018)
Figure Asia-Pacific Gene Editing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Gene Editing by Countries (2017-2018)
Figure Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2017-2018)
Figure China Gene Editing Growth Rate (2017-2018)
Figure China Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Gene Editing Growth Rate (2017-2018)
Figure Japan Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Gene Editing Growth Rate (2017-2018)
Figure Korea Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Gene Editing Growth Rate (2017-2018)
Figure India Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Gene Editing Growth Rate (2017-2018)
Figure Southeast Asia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gene Editing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Gene Editing Growth Rate (2017-2018)
Figure South America Gene Editing Revenue and Growth Rate (2017-2018)
Figure South America Gene Editing by Countries (2017-2018)
Figure South America Gene Editing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Gene Editing Growth Rate (2017-2018)
Figure Brazil Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Gene Editing Growth Rate (2017-2018)
Figure Argentina Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Gene Editing Growth Rate (2017-2018)
Figure Columbia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Gene Editing Growth Rate (2017-2018)
Figure Rest of South America Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Gene Editing Growth Rate (2017-2018)
Figure Middle East and Africa Gene Editing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Gene Editing by Countries (2017-2018)
Figure Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Gene Editing Growth Rate (2017-2018)
Figure Saudi Arabia Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Gene Editing Growth Rate (2017-2018)
Figure United Arab Emirates Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Gene Editing Growth Rate (2017-2018)
Figure Egypt Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Gene Editing Growth Rate (2017-2018)
Figure Nigeria Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Gene Editing Growth Rate (2017-2018)
Figure South Africa Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Gene Editing Growth Rate (2017-2018)
Figure Turkey Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gene Editing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gene Editing Revenue (Millions USD) and Growth Rate (2017-2018)
Table Sangamo Biosciences Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Parker Institute Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Editas Medicine Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Intellia Therapeutics Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cellectis Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Crispr Therapeutics Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Alma Lasers Ltd. Gene Editing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Gene Editing Market Share by Manufacturer
Figure Global Gene Editing Revenue and Market Share by Manufacturer
Table Global Gene Editing Price by Region (2017-2017)
Figure Top 5 Gene Editing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Gene Editing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Gene Editing Market Forecast by Regions (2018-2025)
Figure North America Gene Editing Market Forecast (2018-2025)
Figure United States Gene Editing Market Forecast (2018-2025)
Figure Canada Gene Editing Market Forecast (2018-2025)
Figure Mexico Gene Editing Market Forecast (2018-2025)
Figure Europe Gene Editing Market Forecast (2018-2025)
Figure Germany Gene Editing Market Forecast (2018-2025)
Figure France Gene Editing Market Forecast (2018-2025)
Figure UK Gene Editing Market Forecast (2018-2025)
Figure Russia Gene Editing Market Forecast (2018-2025)
Figure Italy Gene Editing Market Forecast (2018-2025)
Figure Rest of Europe Gene Editing Market Forecast (2018-2025)
Figure Asia-Pacific Gene Editing Market Forecast (2018-2025)
Figure China Gene Editing Market Forecast (2018-2025)
Figure Japan Gene Editing Market Forecast (2018-2025)
Figure Korea Gene Editing Market Forecast (2018-2025)
Figure India Gene Editing Market Forecast (2018-2025)
Figure Southeast Asia Gene Editing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Gene Editing Market Forecast (2018-2025)
Figure South America Gene Editing Market Forecast (2018-2025)
Figure Brazil Gene Editing Market Forecast (2018-2025)
Figure Argentina Gene Editing Market Forecast (2018-2025)
Figure Columbia Gene Editing Market Forecast (2018-2025)
Figure Rest of South America Gene Editing Market Forecast (2018-2025)
Figure Middle East and Africa Gene Editing Market Forecast (2018-2025)
Figure Saudi Arabia Gene Editing Market Forecast (2018-2025)
Figure United Arab Emirates Gene Editing Market Forecast (2018-2025)
Figure Egypt Gene Editing Market Forecast (2018-2025)
Figure Nigeria Gene Editing Market Forecast (2018-2025)
Figure South Africa Gene Editing Market Forecast (2018-2025)
Figure Turkey Gene Editing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Gene Editing Market Forecast (2018-2025)
Figure Global Gene Editing Forecast by Product (2018-2025)
Figure Global Gene Editing Market Share Forecast by Product (2018-2025)
Figure Global Gene Editing Forecast by Product (2018-2025)
Figure Global Gene Editing Forecast by Technology (2018-2025)
Figure Global Gene Editing Market Share Forecast by Technology (2018-2025)
Figure Global Gene Editing Forecast by Technology (2018-2025)
Figure Global Gene Editing Forecast by Application (2018-2025)
Figure Global Gene Editing Market Share Forecast by Application (2018-2025)
Figure Global Gene Editing Forecast by Application (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|